Daily Archives: September 24, 2020

Philips expands peripheral vascular disease portfolio with the QuickClear mechanical thrombectomy system for blood clot removal

September 24, 2020

  • Powerfully simple thrombectomy solution provides physicians with an all-in-one, single-use aspiration catheter and pump system
  • Intuitive design eliminates the need for capital equipment, with easy setup supporting faster procedures times
  • Significantly smaller footprint provides the same or greater aspiration power as currently-available thrombectomy devices [1]      

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the innovative QuickClear mechanical thrombectomy system. The compact, single-use system provides an all-in-one aspiration pump and catheter for the removal of blood clots from the vessels of the peripheral arterial and venous systems [2]. The system’s innovative all-in-one design is simple to use while eliminating the need for capital equipment or costly accessories, with easy setup supporting faster procedures times. The Philips QuickClear Mechanical Thrombectomy System has received U.S. FDA 510(k) clearance and is available for sale in the U.S.

“This novel thrombectomy system is the latest addition to Philips’ market-leading portfolio for the diagnosis and treatment of peripheral vascular diseases,” said Chris Landon, Senior Vice President and General Manager Image Guided Therapy Devices at Philips. “Its intuitive design simplifies the entire thrombectomy procedure workflow. By taking away the high initial capital expenditure costs associated with traditional mechanical thrombectomy systems, QuickClear can help bring cost-effective solutions to both the hospital and outpatient care settings.”

Simple, optimized performance
QuickClear simplifies the entire thrombectomy procedure workflow. The small footprint of the sterile device allows it to be placed easily and conveniently on the table next to the patient. With the touch of a button, the system is up and running at maximum aspiration power within seconds. The consistency of the aspiration power during the procedure provides physicians more control and supports faster procedure times. The system’s range of catheters includes a large 10F aspiration catheter, providing 59% more aspiration volume than 8F aspiration catheters [1].

“QuickClear is a simple and easy to use mechanical thrombectomy system,” said Bryan Fisher, MD, Chief of Vascular Surgery, Tristar Centennial Medical Center, Nashville, U.S. “The system is significantly smaller than other systems without compromising aspiration power. The convenience of the device really shines through with its single use and lack of capital equipment. I am excited about the potential of this device and the impact it will have on my practice and the patients I treat.”

Philips’ peripheral vascular portfolio already includes advanced interventional imaging systems for precision guidance; intravascular ultrasound (IVUS) catheters to assess the location of the disease and lesion morphology and guide and confirm the treatment; peripheral atherectomy devices to remove blockages; and peripheral therapy devices, such as Philips’ Stellarex drug-coated balloon, to treat lesions. Philips recently further extended this portfolio with the acquisition of Intact Vascular, maker of the Tack Endovascular System, a first-of-its-kind, minimal-metal, dissection repair device that provides precision treatment of peripheral arterial dissections following balloon angioplasty in above-the-knee (ATK) and below-the-knee (BTK) therapeutic interventions.

New Cardiovascular Horizons digital symposium
Today, September 24th at 19:00 ET Philips will host a symposium entitled ‘QuickClear Mechanical Thrombectomy System: A Powerfully Simple and Cost-Effective Solution’ as part of the New Cardiovascular Horizons (NCVH) digital education series. To register, visit here.

The Philips QuickClear Mechanical Thrombectomy System is U.S. FDA 510(k) cleared and available for sale in the U.S., with future expansion of availability to other geographies planned.

[1] Testing performed in-house. Data on file.
[2] The Philips QuickClear mechanical thrombectomy system is indicated for the removal of soft, fresh emboli and thrombi from the vessels of the peripheral arterial and venous systems.

For further information, please contact:

Mark Groves
Philips Global Press Office
Tel: +31 631 639 916
Email: mark.groves@philips.com

Twitter: mark_groves

Fabienne van der Feer
Philips Image Guided Therapy
Tel: +31 622 698 001
Email: fabienne.van.der.feer@philips.com

Twitter: FC_Feer

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

Virtusa Named a Leader in Digital Process Automation by Independent Research Firm

SOUTHBOROUGH, Mass., Sept. 23, 2020 (GLOBE NEWSWIRE) — Virtusa Corporation (NASDAQ GS: VRTU), a global provider of digital strategy, digital engineering, and IT services and solutions that help clients change and disrupt markets through innovation engineering, announced that Forrester Research has named Virtusa a Leader in The Forrester Wave™: Digital Process Automation Service Providers, Q3 2020 evaluation.

The Forrester Wave evaluates the most significant providers in the Digital Process Automation (DPA) marketplace and shows how each provider measures up against changing customer expectations to help technology and business decision makers select the right provider for their DPA low-code/no-code needs. Forrester evaluated 13 DPA Service Providers, and Virtusa was positioned as a Leader based on the scores in the current offering, strategy, and market presence categories.

According to the report, Virtusa leads process automation projects with a methodology to align delivery with application modernization. Its methodology assesses the existing technology landscape and includes enterprise architects in the delivery process to ensure technology alignment.

“Virtusa’s domain consultants, designers, and engineers lead digital transformation for our clients through innovative industry solutions and our deep digital engineering expertise,” said Samir Dhir, president and head of Americas, Virtusa. “We believe being positioned as a Leader in this evaluation by Forrester Research underscores that Virtusa’s consulting-led, data-driven DPA no-code/low-code approach is helping accelerate and optimize the digital transformation journey for our clients.”

Virtusa helps clients use digital process automation to increase the delivery speed and reduce the costs of business-critical digital transformation projects through its Digital Transformation Studio (DTS). DTS allows Virtusa teams to set specific performance goals with each client focused on areas including reducing technical debt, improving time to market, or reducing costs and is now being leveraged through various use cases across its representative client industries including banking, healthcare, life sciences, insurance, telecommunications, media, and technology.

Read the complimentary copy of the full The Forrester Wave™: Digital Process Automation Service Providers, Q3 2020 evaluation at virtusa.com/lp/forrester-wave-leader

The Forrester Wave™ is copyrighted by Forrester Research, Inc. Forrester and Forrester Wave™ are trademarks of Forrester Research, Inc. The Forrester Wave™ is a graphical representation of Forrester’s call on a market and is plotted using a detailed spreadsheet with exposed scores, weightings, and comments. Forrester does not endorse any vendor, product, or service depicted in the Forrester Wave™. Information is based on best available resources. Opinions reflect judgment at the time and are subject to change.

About Virtusa
Virtusa Corporation (NASDAQ GS: VRTU) is a global provider of digital business strategy, digital engineering, and information technology (IT) services and solutions that help clients change, disrupt, and unlock new value through innovation engineering. Virtusa serves Global 2000 companies in the Banking, Financial Services, Insurance, Healthcare, Communications, Media, Entertainment, Travel, Manufacturing, and Technology industries.

Virtusa helps clients grow their business with innovative products and services that create operational efficiency using digital labor, future-proof operational and IT platforms, and rationalization and modernization of IT applications infrastructure. This is achieved through a unique approach blending deep contextual expertise, empowered agile teams, and measurably better engineering to create holistic solutions that drive business forward at unparalleled velocity enabled by a culture of cooperative disruption.

Virtusa is a registered trademark of Virtusa Corporation. All other company and brand names may be trademarks or service marks of their respective holders.

Contact:
Ron Favali
Conversion Marketing
727-512-4490
ron@conversionam.com